CLOs on the Move

Covalent Medical Inc

www.covamed.com

 
Covalent Medical Inc is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.covamed.com
  • 4750 S State Rd
    Ann Arbor, MI USA 48108
  • Phone: 734.429.2451

Executives

Name Title Contact Details

Similar Companies

Nobel Biocare United States

Nobel Biocare is a world leader in the field of innovative implant-based dental restorations – from single-tooth to fully edentulous indications.

Emrn Inc

Emrn Inc is a Le Gardeur, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Jones County Medical Supplies

Jones County Medical Supplies is a Laurel, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

INNOVATIVE BIOCERAMIX

INNOVATIVE BIOCERAMIX INC. is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

NeuroOne Incorporated

NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.